Condition
Hepatitis E Infection
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (2)
P 4 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06631560Not ApplicableCompletedPrimary
Hepatitis E Virus Infection in Oncological Patients
NCT05808166Phase 2RecruitingPrimary
Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women
NCT02759991Phase 4CompletedPrimary
Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.
NCT01698723Phase 2Unknown
A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus
Showing all 4 trials